These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 33515428)

  • 41. Intranasal Insulin Prevents Anesthesia-induced Cognitive Impairments in Aged Mice.
    Li X; Run X; Wei Z; Zeng K; Liang Z; Huang F; Ke D; Wang Q; Wang JZ; Liu R; Zhang B; Wang X
    Curr Alzheimer Res; 2019; 16(1):8-18. PubMed ID: 30381076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. siRNA Mediated GSK3β Knockdown Targets Insulin Signaling Pathway and Rescues Alzheimer's Disease Pathology: Evidence from
    Gupta S; Singh V; Ganesh S; Singhal NK; Sandhir R
    ACS Appl Mater Interfaces; 2022 Jan; 14(1):69-93. PubMed ID: 34967205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intranasal Insulin Ameliorates Cerebral Hypometabolism, Neuronal Loss, and Astrogliosis in Streptozotocin-Induced Alzheimer's Rat Model.
    Chen Y; Guo Z; Mao YF; Zheng T; Zhang B
    Neurotox Res; 2018 May; 33(4):716-724. PubMed ID: 28929339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild-moderate Alzheimer's disease.
    Rosenbloom MH; Barclay TR; Pyle M; Owens BL; Cagan AB; Anderson CP; Frey WH; Hanson LR
    CNS Drugs; 2014 Dec; 28(12):1185-9. PubMed ID: 25373630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of intranasal insulin on cognitive function: a systematic review.
    Shemesh E; Rudich A; Harman-Boehm I; Cukierman-Yaffe T
    J Clin Endocrinol Metab; 2012 Feb; 97(2):366-76. PubMed ID: 22162476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intranasal H102 Peptide-Loaded Liposomes for Brain Delivery to Treat Alzheimer's Disease.
    Zheng X; Shao X; Zhang C; Tan Y; Liu Q; Wan X; Zhang Q; Xu S; Jiang X
    Pharm Res; 2015 Dec; 32(12):3837-49. PubMed ID: 26113236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Editorial: Siegfried Hoyer's concept of Alzheimer pathophysiology.
    Frölich L; Müller WE; Riederer P
    J Neural Transm (Vienna); 2015 Apr; 122(4):495-7. PubMed ID: 25616721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.
    Zhong KL; Chen F; Hong H; Ke X; Lv YG; Tang SS; Zhu YB
    Metab Brain Dis; 2018 Aug; 33(4):1009-1018. PubMed ID: 29626315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art.
    de la Monte SM
    Expert Opin Drug Deliv; 2013 Dec; 10(12):1699-709. PubMed ID: 24215447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intranasal Insulin Improves Age-Related Cognitive Deficits and Reverses Electrophysiological Correlates of Brain Aging.
    Maimaiti S; Anderson KL; DeMoll C; Brewer LD; Rauh BA; Gant JC; Blalock EM; Porter NM; Thibault O
    J Gerontol A Biol Sci Med Sci; 2016 Jan; 71(1):30-9. PubMed ID: 25659889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution of insulin in trigeminal nerve and brain after intranasal administration.
    Lochhead JJ; Kellohen KL; Ronaldson PT; Davis TP
    Sci Rep; 2019 Feb; 9(1):2621. PubMed ID: 30796294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.
    Watson GS; Craft S
    CNS Drugs; 2003; 17(1):27-45. PubMed ID: 12467491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Targeting the brain through the nose. Effects of intranasally administered insulin].
    Brünner YF; Benedict C; Freiherr J
    Nervenarzt; 2013 Aug; 84(8):949-54. PubMed ID: 23760596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
    Reger MA; Watson GS; Green PS; Wilkinson CW; Baker LD; Cholerton B; Fishel MA; Plymate SR; Breitner JC; DeGroodt W; Mehta P; Craft S
    Neurology; 2008 Feb; 70(6):440-8. PubMed ID: 17942819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice.
    Chen Y; Zhao Y; Dai CL; Liang Z; Run X; Iqbal K; Liu F; Gong CX
    Exp Neurol; 2014 Nov; 261():610-9. PubMed ID: 24918340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease.
    Watson GS; Craft S
    Eur J Pharmacol; 2004 Apr; 490(1-3):97-113. PubMed ID: 15094077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination of Insulin with a GLP1 Agonist Is Associated with Better Memory and Normal Expression of Insulin Receptor Pathway Genes in a Mouse Model of Alzheimer's Disease.
    Robinson A; Lubitz I; Atrakchi-Baranes D; Licht-Murava A; Katsel P; Leroith D; Liraz-Zaltsman S; Haroutunian V; Beeri MS
    J Mol Neurosci; 2019 Apr; 67(4):504-510. PubMed ID: 30635783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
    Femminella GD; Frangou E; Love SB; Busza G; Holmes C; Ritchie C; Lawrence R; McFarlane B; Tadros G; Ridha BH; Bannister C; Walker Z; Archer H; Coulthard E; Underwood BR; Prasanna A; Koranteng P; Karim S; Junaid K; McGuinness B; Nilforooshan R; Macharouthu A; Donaldson A; Thacker S; Russell G; Malik N; Mate V; Knight L; Kshemendran S; Harrison J; Hölscher C; Brooks DJ; Passmore AP; Ballard C; Edison P
    Trials; 2019 Apr; 20(1):191. PubMed ID: 30944040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Obese men respond to cognitive but not to catabolic brain insulin signaling.
    Hallschmid M; Benedict C; Schultes B; Born J; Kern W
    Int J Obes (Lond); 2008 Feb; 32(2):275-82. PubMed ID: 17848936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparable sensitivity of postmenopausal and young women to the effects of intranasal insulin on food intake and working memory.
    Krug R; Benedict C; Born J; Hallschmid M
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E468-72. PubMed ID: 20719831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.